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Background
•	 	Techniques for anatomic pulmonary resection:
	 	 -	 	Rib-sparing	thoracotomy-	current	standard	of	
care
	 	 -	 	Video-assisted	thoracoscopic	surgery-	similar	
perioperative	and	oncologic	efficacy
	 	 -	 	Robotic-Assisted	Lung	resection-	newer	
minimally	invasive	option
•	 	Theoretical advantages of robotic lung surgery: 
7 degrees of freedom, 3-D Hi-Definition camera, 
dampens tremor, no fulcrum effect, operating 
surgeon may use three arms simultaneously, seated 
position more comfortable for operating surgeon
•	 	Few studies to date evaluate robotic-assisted 
segmentectomy for lung lesions. We present 
our initial experience with robotic assisted 
segmentectomy at LVHN with previously established 
data on the topic.
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TABLE 1. 

















Szwerc et al 2014 34 R 2.6 132 52 0 23.53 9 4.9 (3.3)
Pardolesi et al 2014 17 R 5 189 NS 0 17.6 NS NS
Gossot et al 2013 117 V 5.5 181 77 NS 11.7 NS 21 (3.5)
Qian et al 2013 35 V 6.2 125 162.5 2.86 8.3 10.9 NS
Leshnower et al 2010 15 V 3.5 145 NS 0 0 NS 4 (3)
Leshnower et al 2010 26 0 8.3 140 NS 8 35 NS 6 (3)
Witte et al 2010 20 V 8.5 212 NS 0 25 NS NS (4.5)
Watanabe et al 2009 41 V NS 220 183 NS 9.7 70 25 (8)
Schuchert et al 2009 104 V 6.4 136 171 0 26.0 16.2 6.4
Schuchert et al 2009 121 0 8.2 143 220 1.65 33.9 28.2 9.1
Oizumi et al 2009 29 V NS 216 100 0 6.9 NS NS
Atkins et al 2007 48 V 4.3 136 250 0 31.3 NS NS (4.1)
Atkins et al 2007 29 0 6.8 130 280 6.9 34.5 NS NS (3.9)
Shiraishi et al 2004 34 V 12.7 240 169 0 11.8 21.9 NS





























•	 	Retrospective review of all robotic segmentectomies 
performed at LVHN 
•	 	October 2011 through June 2014: 186 robotic 
pulmonary resections performed. 
•	 	Total of	36 robotic anatomic segmentectomies
•	 	Perioperative outcomes evaluated: Length of stay, 
operating room time, conversion rate, estimated 
blood loss, 30-day mortality, hospital based 
complications, number of lymph nodes, tumor size, 
surgical margin, FEV1, recurrence.  Conversions were 
excluded in analysis.   
•	 	All cases were 
performed by a 
single surgeon 
(M.F.S) with the 




•	 	Only about 20-30% of all anatomic lung resections are performed 
using VATS.
•	 	Technical difficulty of VATS may be a barrier to minimally invasive 
chest surgery, which robotic surgery may overcome.
•	 	Current literature suggests that robotic surgery may offer similar 
results as VATS but with a 
faster learning curve.
•	 	Longer follow-up period 
is needed to assess long 
term oncologic efficacy. 
Cost analysis should be 
performed to evaluate if the 
higher price of the robotic 
systems outweigh the 
possibly decreased OR time 
and hospital stay. 
Results
•	 	Conversion rate 5.5% (2/36); excluded from further analysis
Conclusion
•	 	The study demonstrates the feasibility, safety, and efficacy of 
robotic-assisted pulmonary segmentectomy for the treatment of 
isolated lung tumors.  
•	 	Robotic-assisted segmentectomy appears to offer shorter length 
of stay, EBL, and OR time than video-assisted or open techniques 
[3-11].   Further studies would be needed to compare robotic 
segmentectomies to VATS procedures.
•	 	Robotic-assisted segmentectomy an may be a beneficial procedure 
in the treatment of early stage lung tumors, as it can be performed 




















OR time vs. Operation number
	 	 -	 	Mean	age:	65.4(41-83)
	 	 -	 	Mean	EBL:	51.9mL	(20-150)
	 	 -	 	Mean	tumor	size	was	1.57cm	
(0.7-3)
	 	 -	 	Mean	lymph	nodes	removed:	
4.85	(	0-10)	
	 	 -	 	Median	Length	of	stay:	2	days
	 	 -	 	Complication	rate:	23.53%
	 	 -	 	Mean	BMI:	27.9(17.9-42.3)
	 	 -	 	Mean	OR	time:	121	minutes	
(49-315)
	 	 -	 	Positive	margins:	0/34
	 	 -	 	Mean	Lymph	node	stations:	
3.32	(	0-7)	
	 	 -	 	Readmission	rate	was	
11.76%	(n=	4/34)
Figure 1.
OR Time vs. peration Number
Table 1.  This table presents some results alongside of previously published data. Compared to the other 
published date, our results have the lowest intraoperative estimated blood loss as well as post-operative length 
of stay.
Using the robotic Da Vinci robotic platform during 
thoracic surgery.
Figure 1.  This graph depicts the operation time in minutes versus the operation number in consecutive 
order. The best fit line depicts a decrease in operating time as the number of operations increases. 
